Search Results - "Rohrer, C."

Near‐infrared fluorescent image‐guided lymph node dissection compared with locoregional lymphadenectomies in dogs with mast cell tumours by Beer, P., Rohrer‐Bley, C., Nolff, M. C.

“…Objectives Near‐infrared fluorescent imaging has been described for intraoperative mapping of the draining lymph nodes in human cancer and canine oral tumours…”
Get full text

Principles for ethical treatment decision‐making in veterinary oncology by Rohrer Bley, C.

“…Many owners of companion animals with cancer are overwhelmed by having to choose the “right course of action.” With the aim of reducing the burden on owners…”
Get full text

Measurement of the Band Bending and Surface Dipole at Chemically Functionalized Si(111)/Vacuum Interfaces by Gleason-Rohrer, David C, Brunschwig, Bruce S, Lewis, Nathan S

“…The core-level energy shifts observed using X-ray photoelectron spectroscopy (XPS) have been used to determine the band bending at Si(111) surfaces terminated…”
Get full text

Can we estimate the accuracy of ADME–Tox predictions? by Tetko, Igor V., Bruneau, Pierre, Mewes, Hans-Werner, Rohrer, Douglas C., Poda, Gennadiy I.

“…There have recently been developments in the methods used to access the accuracy of the prediction and applicability domain of absorption, distribution,…”
Get full text

The role of sentinel lymph node mapping in small animal veterinary medicine: A comparison with current approaches in human medicine by Beer, P., Pozzi, A., Rohrer Bley, C., Bacon, N., Pfammatter, N. S., Venzin, C.

“…The relevance of regional lymph node (LN) assessment to quantify the metastatic spread of cancer is well recognized in veterinary oncology. Evaluation of LNs…”
Get full text

Genome-Wide Associations and Functional Genomic Studies of Musculoskeletal Adverse Events in Women Receiving Aromatase Inhibitors by Ingle, James N, Schaid, Daniel J, Goss, Paul E, Liu, Mohan, Mushiroda, Taisei, Chapman, Judy-Anne W, Kubo, Michiaki, Jenkins, Gregory D, Batzler, Anthony, Shepherd, Lois, Pater, Joseph, Wang, Liewei, Ellis, Matthew J, Stearns, Vered, Rohrer, Daniel C, Goetz, Matthew P, Pritchard, Kathleen I, Flockhart, David A, Nakamura, Yusuke, Weinshilboum, Richard M

“…We performed a case-control genome-wide association study (GWAS) to identify single nucleotide polymorphisms (SNPs) associated with musculoskeletal adverse…”
Get full text

Feasibility study in combined direct metal deposition (DMD) and plasma transfer arc welding (PTA) additive manufacturing by Dalaee, M., Cheaitani, F., Arabi-Hashemi, A., Rohrer, C., Weisse, B., Leinenbach, C., Wegener, K.

“…Direct metal deposition (DMD) and plasma transfer arc welding (PTA) are two metal deposition techniques, which are well-known for high-quality and…”
Get full text

In vitro fermentation of nuts results in the formation of butyrate and c9,t11 conjugated linoleic acid as chemopreventive metabolites by Schlörmann, W., Birringer, M., Lochner, A., Lorkowski, S., Richter, I., Rohrer, C., Glei, M.

“…Purpose The consumption of foods rich in dietary fiber and polyunsaturated fatty acids such as nuts can contribute to a healthy diet. Therefore, the formation…”
Get full text

Outcome in dogs with advanced (stage 3b) anal sac gland carcinoma treated with surgery or hypofractionated radiation therapy by Meier, V., Polton, G., Cancedda, S., Roos, M., Laganga, P., Emmerson, T., Rohrer Bley, C.

“…Stage 3b anal sac gland carcinoma (ASGC) can be life‐threatening. A surgical approach is not always possible or may be declined. Dogs with stage 3b ASGC…”
Get full text

Survival analysis of dogs with advanced primary lung carcinoma treated by metronomic cyclophosphamide, piroxicam and thalidomide by Polton, G., Finotello, R., Sabattini, S., Rossi, F., Laganga, P., Vasconi, M. E., Barbanera, A., Stiborova, K., Rohrer Bley, C., Marconato, L.

“…Unresectable or metastatic (advanced) primary pulmonary carcinoma (PPC) represents a therapeutic challenge where surgery may be contraindicated and the…”
Get full text

A prospective pilot study on early toxicity from a simultaneously integrated boost technique for canine sinonasal tumours using image‐guided intensity‐modulated radiation therapy by Soukup, A., Meier, V., Pot, S., Voelter, K., Rohrer Bley, C.

“…In order to overcome the common local treatment failure of canine sinonasal tumours, integrated boost techniques were tried in the cobalt/orthovoltage era, but…”
Get full text

A complication probability planning study to predict the safety of a new protocol for intracranial tumour radiotherapy in dogs by Rohrer Bley, C., Meier, V., Schwarz, P., Roos, M., Besserer, J.

“…Technical advances make it possible to deliver radiation therapy for canine intracranial tumours in fewer fractions, under the assumption of equivalent tumour…”
Get full text

Efficacy and side effects of radiation therapy in comparison with radiation therapy and temozolomide in the treatment of measurable canine malignant melanoma by Cancedda, S., Rohrer Bley, C., Aresu, L., Dacasto, M., Leone, V. F., Pizzoni, S., Gracis, M., Marconato, L.

“…Prognosis for unresectable canine malignant melanoma (MM) is typically poor, and therapeutic approaches remain largely palliative. A bi‐institutional trial was…”
Get full text

Dosimetric benefit of adaptive radiotherapy in the neoadjuvant management of canine and feline thymoma—An exploratory case series by Rohrer Bley, C., Meier, V., Schneider, U.

“…While surgery is the treatment of choice for thymomas, complete excision is not possible in a significant proportion of cases. For these patients, radiotherapy…”
Get full text

Practical evaluation of a warm-reactive anti-M by Yang, X, Syrjamaki, J M, Ruegsegger, P A, Rohrer, C T, Rose, W N

“…Anti-M is usually a naturally occurring antibody directed against M in the MNS blood group system. It does not require exposure to the antigen from previous…”
Get more information

An Open‐label Phase 1 Dose‐escalation Clinical Trial of a Single Intravenous Administration of Gemcitabine in Dogs with Advanced Solid Tumors by Marconato, L., Finotello, R., Bonfanti, U., Dacasto, M., Beatrice, L., Pizzoni, S., Leone, V.F., Balestra, G., Furlanello, T., Rohrer Bley, C., Aresu, L.

“…Background A broad range of gemcitabine dosages have been used in dogs. Hypothesis/Objectives To determine maximally tolerated dose (MTD), dose‐limiting…”
Get full text

Use of Epothilone B (Patupilone) in Refractory Lymphoma and Advanced Solid Tumors in Dogs by Meier, V., Geigy, C., Grosse, N., McSheehy, P., Rohrer Bley, C.

“…Background The epothilones are microtubule‐stabilizing agents with promising antitumor effect in refractory and metastatic tumors in humans. The toxicity…”
Get full text

Novel hyperthermia applicator system allows adaptive treatment planning: Preliminary clinical results in tumour‐bearing animals by Dressel, S., Gosselin, M.‐C., Capstick, M. H., Carrasco, E., Weyland, M. S., Scheidegger, S., Neufeld, E., Kuster, N., Bodis, S., Rohrer Bley, C.

“…Hyperthermia (HT) as an adjuvant to radiation therapy (RT) is a multimodality treatment method to enhance therapeutic efficacy in different tumours. High…”
Get full text

Metastasized Leydig cell tumor in a dog by Togni, A, Rütten, M, Bley, C Rohrer, Hurter, K

“…We present the clinical findings, diagnosis and treatment of an 11-year old intact male Fox Terrier with a malignant Leydig cell tumor of the right testicle,…”
Get more information

Safety, tolerability and pharmacokinetic properties of the novel triazene TriN 2755 in tumour bearing dogs – a phase I study by Athanasiadi, I., Geigy, C., Hilger, R. A., Meier, V., Rohrer Bley, C.

“…TriN 2755 is an alkylating antineoplastic agent for intravenous (IV) use, carrying the triazene group as the cytotoxic principal. Using a standard 3 + 3…”
Get full text